These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 17288757)
1. [Effect of pre-angiography use of tirofiban in patients with acute ST-elevation myocardial infarction treated by primary percutaneous coronary intervention]. Xu L; Yang XC; Wang LF; Ge YG; Wang HS; Li WM; Ni ZH; Liu Y; Cui L Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Nov; 34(11):983-6. PubMed ID: 17288757 [TBL] [Abstract][Full Text] [Related]
2. Comparison of reperfusion regimens with or without tirofiban in ST-elevation acute myocardial infarction. Martínez-Ríos MA; Rosas M; González H; Peña-Duque MA; Martínez-Sánchez C; Gaspar J; García H; Gaxiola E; Delgado L; Carrillo J; Leyva JL; Lupi E; Am J Cardiol; 2004 Feb; 93(3):280-7. PubMed ID: 14759375 [TBL] [Abstract][Full Text] [Related]
3. The effect of pre-hospital glycoprotein IIb-IIIa inhibitors on angiographic outcome in STEMI patients who are candidates for primary PCI. Hermanides RS; van Werkum JW; Ottervanger JP; Breet NJ; Gosselink AT; van Houwelingen KG; Dambrink JH; Hamm C; ten Berg JM; van 't Hof AW; Catheter Cardiovasc Interv; 2012 May; 79(6):956-64. PubMed ID: 22162050 [TBL] [Abstract][Full Text] [Related]
4. Facilitation of primary coronary angioplasty by early start of a glycoprotein 2b/3a inhibitor: results of the ongoing tirofiban in myocardial infarction evaluation (On-TIME) trial. van 't Hof AW; Ernst N; de Boer MJ; de Winter R; Boersma E; Bunt T; Petronio S; Marcel Gosselink AT; Jap W; Hollak F; Hoorntje JC; Suryapranata H; Dambrink JH; Zijlstra F; Eur Heart J; 2004 May; 25(10):837-46. PubMed ID: 15140531 [TBL] [Abstract][Full Text] [Related]
5. Safety and feasibility of a novel dosing regimen of tirofiban administered in patients with acute myocardial infarction with ST elevation before primary coronary angioplasty: a pilot study. Kochman W; Dobrzycki S; Nowak KS; Chlopicki S; Kralisz P; Prokopczuk P; Bachorzewska-Gajewska H; Gugala K; Niewada M; Mezynski G; Poniatowski B; Korecki J; Musial WJ J Thromb Thrombolysis; 2004 Apr; 17(2):127-31. PubMed ID: 15306748 [TBL] [Abstract][Full Text] [Related]
7. Effect of tirofiban plus clopidogrel and aspirin on primary percutaneous coronary intervention via transradial approach in patients with acute myocardial infarction. Fu XH; Hao QQ; Jia XW; Fan WZ; Gu XS; Wu WL; Hao GZ; Li SQ; Jiang YF; Geng W Chin Med J (Engl); 2008 Mar; 121(6):522-7. PubMed ID: 18364139 [TBL] [Abstract][Full Text] [Related]
8. [Effects of intracoronary or intravenous tirofiban administration in patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention]. Yang XC; Zhang DP; Wang LF; Xu L; Ge YG; Wang HS; Li WM; Ni ZH; Xia K; Lian Y; Xue YL; Ma LX Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jun; 35(6):517-22. PubMed ID: 17711710 [TBL] [Abstract][Full Text] [Related]
9. Changes in BNP, hs-CRP and TIMI risk index with addition of tirofiban during primary percutaneous coronary intervention for acute STEMI: a prospective observational cohort study. Kurt IH; Demirkol S; Ünal I; Batur MK Anadolu Kardiyol Derg; 2012 Mar; 12(2):107-14. PubMed ID: 22281789 [TBL] [Abstract][Full Text] [Related]
10. [Short- or long-outcome of early tirofiban in ST-segment elevated acute myocardial infarction undergoing elective percutaneous coronary intervention]. Zhang Y; Gao C; Li M; Liu H; Wang X; Yang H; Wang X; Zhu Z; Hu D Zhonghua Nei Ke Za Zhi; 2014 Apr; 53(4):273-7. PubMed ID: 24857299 [TBL] [Abstract][Full Text] [Related]
11. [Clinical outcomes and safety of primary percutaneous coronary intervention combined with tirofiban therapy in patients with acute ST-segment elevation myocardial infarction]. Shen J; Zhang Q; Zhang RY Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Nov; 35(11):1005-9. PubMed ID: 18269820 [TBL] [Abstract][Full Text] [Related]
12. Impact of tirofiban on angiographic morphologic features of high-burden thrombus formation during direct percutaneous coronary intervention and short-term outcomes. Yip HK; Wu CJ; Chang HW; Hsieh YK; Fang CY; Chen SM; Chen MC Chest; 2003 Sep; 124(3):962-8. PubMed ID: 12970024 [TBL] [Abstract][Full Text] [Related]
13. Achieved platelet aggregation inhibition after different antiplatelet regimens during percutaneous coronary intervention for ST-segment elevation myocardial infarction. Ernst NM; Suryapranata H; Miedema K; Slingerland RJ; Ottervanger JP; Hoorntje JC; Gosselink AT; Dambrink JH; de Boer MJ; Zijlstra F; van 't Hof AW J Am Coll Cardiol; 2004 Sep; 44(6):1187-93. PubMed ID: 15364318 [TBL] [Abstract][Full Text] [Related]
14. [Efficacy comparison of combined intracoronary administration of high-dose adenosine and tirofiban versus intracoronary tirofiban during primary percutaneous coronary intervention in patients with acute myocardial infarction]. Tong ZC; Li Q; Chen M; Miao GB; Wei Y; Li FO; Zhao H; Zhang JJ Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Oct; 41(10):839-44. PubMed ID: 24377889 [TBL] [Abstract][Full Text] [Related]
15. Facilitated percutaneous coronary intervention (PCI) in patients with acute ST-elevation myocardial infarction: comparison of prehospital tirofiban versus fibrinolysis before direct PCI. Möckel M; Bocksch W; Strohm S; Kühnle Y; Vollert J; Nibbe L; Dietz R Int J Cardiol; 2005 Aug; 103(2):193-200. PubMed ID: 16080980 [TBL] [Abstract][Full Text] [Related]
16. Adjunctive platelet glycoprotein IIb/IIIa receptor inhibition with tirofiban before primary angioplasty improves angiographic outcomes: results of the TIrofiban Given in the Emergency Room before Primary Angioplasty (TIGER-PA) pilot trial. Lee DP; Herity NA; Hiatt BL; Fearon WF; Rezaee M; Carter AJ; Huston M; Schreiber D; DiBattiste PM; Yeung AC; Circulation; 2003 Mar; 107(11):1497-501. PubMed ID: 12654606 [TBL] [Abstract][Full Text] [Related]
17. Effect of tirofiban therapy on ST segment resolution and clinical outcomes in patients with ST segment elevated acute myocardial infarction undergoing primary angioplasty. Uyarel H; Uzunlar B; Unal Dayi S; Tartan Z; Samur H; Kasikcioglu H; Akgul O; Simsek D; Erdem I; Okmen E; Cam N Cardiology; 2006; 105(3):168-75. PubMed ID: 16479104 [TBL] [Abstract][Full Text] [Related]
18. Early administration of abciximab bolus in the emergency department improves angiographic outcome after primary PCI as assessed by TIMI frame count: results of the early ReoPro administration in myocardial infarction (ERAMI) trial. Gabriel HM; Oliveira JA; da Silva PC; da Costa JM; da Cunha JA Catheter Cardiovasc Interv; 2006 Aug; 68(2):218-24. PubMed ID: 16817177 [TBL] [Abstract][Full Text] [Related]
19. Pre-hospital administration of tirofiban in diabetic patients with ST-elevation myocardial infarction undergoing primary angioplasty: a sub-analysis of the On-Time 2 trial. Timmer JR; ten Berg J; Heestermans AA; Dill T; van Werkum JW; Dambrink JH; Suryapranata H; Ottervanger JP; Hamm C; van 't Hof AW; EuroIntervention; 2010 Aug; 6(3):336-42. PubMed ID: 20884411 [TBL] [Abstract][Full Text] [Related]
20. Early vs late administration of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention of acute ST-segment elevation myocardial infarction: a meta-analysis. Montalescot G; Borentain M; Payot L; Collet JP; Thomas D JAMA; 2004 Jul; 292(3):362-6. PubMed ID: 15265852 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]